Actinium Pharmaceuticals(DE:7AY1)
€0.97-0.23 (-19.58%)
DE:7AY1
Actinium Pharmaceuticals earnings date
€0.97
At close:-0.23 (-19.58%)
Actinium Pharmaceuticals (7AY1) Q4 2023 Earnings Report
2 Followers
DE:7AY1 Q4 2023 EPS Results
- Actual EPS
- -EUR 0.31
- Consensus EPS
- -EUR 0.52
- Beat/Miss
- Beat by +EUR 0.21
- One Year Ago EPS
- -EUR 0.38
DE:7AY1 Q4 2023 Revenue Results
- Actual Revenue
- EUR 73.67K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 73.67K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/15/2024
- Time
- TBA
- Conference Call
- Friday, March 15, 2024
DE:7AY1 Upcoming Earnings
Actinium Pharmaceuticals's next earnings date is estimated for November 23, 2026, based on past reporting schedules.
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:7AY1 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 23, 2026 | 2026 (Q3) | -0.19-0.17 | -0.15 | -16.25% (-0.02) | ― |
| Mar 13, 2026 | 2025 (Q4) | -0.17-0.17 | -0.19 | 9.52% (+0.02) | |
| Nov 24, 2025 | 2025 (Q3) | -0.16-0.15 | -0.34 | 56.76% (+0.19) | |
| Mar 14, 2025 | 2024 (Q4) | -0.34-0.19 | -0.31 | 38.24% (+0.12) | |
| Nov 18, 2024 | 2024 (Q3) | -0.35-0.34 | -0.45 | 24.49% (+0.11) | |
| Mar 15, 2024 | 2023 (Q4) | -0.52-0.31 | -0.38 | 19.05% (+0.07) | |
| May 12, 2023 | 2023 (Q1) | ―- | -0.21 | ― | |
| Apr 03, 2023 | 2022 (Q4) | -0.38-0.39 | -0.21 | -86.96% (-0.18) | |
| Aug 09, 2019 | 2019 (Q2) | ―-0.82 | -1.09 | 25.00% (+0.27) | |
| May 10, 2019 | 2019 (Q1) | ―-1.36 | -1.91 | 28.57% (+0.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

